Myc degradation: Dancing with ubiquitin ligases

Two articles, one by Welcker et al. (1) in this issue of PNAS and one in the EMBO Journal (2), report that the F-box protein Fbw7, a component of an SCF-class ubiquitin ligase (E3) complex, mediates recognition and ubiquitination of the c-Myc transcription factor when the latter is phosphorylated on Thr 58. This regulatory connection is conserved throughout evolution, because the Fbw7 homologue Archipelago fulfills the same function for the Drosophila Myc protein, dMyc (3). Here, these findings are discussed alongside recent progress in our understanding of the posttranslational modifications regulating Myc turnover in vivo (4) and previous work connecting another F-box protein, Skp2, to Myc regulation (5, 6). c-Myc (Myc, Fig. 1 A ) is a transcription factor of the basic helix–loop–helix leucine zipper (bHLH-LZ) family. Through dimerization with Max, Myc binds the DNA element CACGTG and contributes to transcriptional activation. Myc also represses transcription at alternative DNA sites through association with other transcriptional activators such as Miz-1. The first 143 residues contain sequences required for both transcriptional activation and repression (7–10) and include two highly conserved “Myc boxes” (MB). MB1 includes threonine-58 (T58) and serine-62 (S62), that are phosphorylated in an interdependent manner: phosphorylation of S62, believed to be catalyzed by ERK kinases (11), is a prerequisite for phosphorylation of T58 by GSK3 (10, 12). Fig. 1. Emergence of a “Myc modification cycle” regulating protein turnover and activity. ( A ) Structure of Myc and Max. ( B ) A series of posttranslational modifications in MB1 regulates Myc's interactions with ubiquitin ligases and may impact its transcriptional activities. Question marks indicate unresolved or hypothetical connections. The importance of T58 in the regulation of Myc function was suggested by observations in human lymphomas. Oncogenic activation of c- myc (e.g., by gene translocation or amplification) commonly results in deregulated expression of c- …

[1]  B. Clurman,et al.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Joseph R. Nevins,et al.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells , 2004, Nature Cell Biology.

[3]  Ying Qi,et al.  Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization* , 2003, Journal of Biological Chemistry.

[4]  L. Larsson,et al.  Implication of the Ubiquitin/Proteasome System in Myc-Regulated Transcription , 2003, Cell cycle.

[5]  K. Nakayama,et al.  The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. , 2003, Molecular cell.

[6]  S. Kim,et al.  Skp2 regulates Myc protein stability and activity. , 2003, Molecular cell.

[7]  M. Muratani,et al.  How the ubiquitin–proteasome system controls transcription , 2003, Nature Reviews Molecular Cell Biology.

[8]  M. Eilers,et al.  Transcriptional repression by Myc. , 2003, Trends in cell biology.

[9]  S. Reed,et al.  hCDC4 gene mutations in endometrial cancer. , 2002, Cancer research.

[10]  G. Evan,et al.  Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression , 2002, Cell.

[11]  S. Lowe,et al.  Dissecting p53 tumor suppressor functions in vivo. , 2002, Cancer cell.

[12]  Robert A. Weinberg,et al.  Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation , 2002, Molecular and Cellular Biology.

[13]  P. Fernandez,et al.  Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. , 2001, Genes & development.

[14]  J. Mestan,et al.  Skp2 is oncogenic and overexpressed in human cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Amati,et al.  Function of the c-Myc oncoprotein in chromatin remodeling and transcription. , 2001, Biochimica et biophysica acta.

[16]  M. Pagano,et al.  Role of the F-box protein Skp2 in lymphomagenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Y Taya,et al.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.

[18]  M. Cole,et al.  The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals , 2000, Molecular and Cellular Biology.

[19]  L. Larsson,et al.  c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. , 2000, Blood.

[20]  Wilhelm Krek,et al.  p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells , 1999, Nature Cell Biology.

[21]  J. Nevins,et al.  Ras enhances Myc protein stability. , 1999, Molecular cell.

[22]  R. Davis,et al.  MAP kinase binds to the NH2‐terminal activation domain of c‐Myc , 1994, FEBS letters.

[23]  L. Penn,et al.  The myc oncogene: MarvelouslY Complex. , 2002, Advances in cancer research.